Sysplatt 75 Tabs
Product Details
Sysplatt 75 Tablet contains Clopidogrel (75mg), an antiplatelet medicine prescribed to prevent blood clots in individuals at risk of heart attack or stroke. It works by inhibiting platelet aggregation, thereby reducing the risk of clot-related cardiovascular events. It is recommended for long-term cardiovascular protection under medical supervision.
Key Features
- Contains Clopidogrel 75mg per tablet
- Prevents blood clots in arteries and veins
- Reduces risk of heart attack and stroke
- Helps maintain smooth blood flow in vessels
- Suitable for patients with cardiovascular risks
- Trusted antiplatelet therapy for long-term use
Enquiry Now
We’re Open to Serve You
- Monday – Friday: 9:00 AM – 7:00 PM
- Saturday : 9:00 AM – 6:00 PM
- Sunday: Closed
Sysplatt 75 Tablet is a prescription medicine formulated with Clopidogrel 75mg, a well-established antiplatelet agent used to reduce the risk of life-threatening cardiovascular events. It is particularly effective in individuals who have experienced a recent heart attack, stroke, or have established peripheral arterial disease. Clopidogrel works by inhibiting platelet aggregation, preventing the formation of dangerous blood clots that can block arteries and lead to heart attacks or strokes.
This medicine helps to maintain healthy blood flow within the blood vessels, reducing the chances of clot-related complications. Sysplatt 75 is typically prescribed alongside other medications such as aspirin for enhanced antiplatelet protection. Regular use, under medical supervision, ensures optimal cardiovascular protection. Patients should follow their physician’s advice regarding dosage and duration and inform their doctor of any history of bleeding disorders or surgeries. Sysplatt 75 is a reliable choice for secondary prevention of thrombotic cardiovascular events in at-risk individuals.
- Prevention of heart attack (myocardial infarction)
- Prevention of stroke
- Treatment after angioplasty or stent placement
- Prevention of peripheral arterial disease complications
- Management of acute coronary syndrome
- Preventing blood clot formation in high-risk individuals
- Reducing risk of cardiovascular events in diabetic patients
- Protection in patients with transient ischemic attacks (TIAs)
- Secondary prevention in patients with atherosclerosis
- Adjunct therapy with aspirin in dual antiplatelet treatment
Sysplatt 75 Tablet contains Clopidogrel, a potent antiplatelet medication. Clopidogrel works by selectively inhibiting the P2Y12 ADP receptor on platelet cell membranes. This inhibition prevents platelets from sticking together, which is the first step in the formation of blood clots. By reducing platelet aggregation, Clopidogrel decreases the chances of clots forming inside arteries that are already narrowed by atherosclerosis (fatty deposits).
These clots are a major cause of heart attacks and strokes. By maintaining blood fluidity, Sysplatt 75 helps ensure continuous, unobstructed blood flow through arteries and veins. It is especially effective when used in combination with aspirin, as part of dual antiplatelet therapy for added protection after stent placement or in patients with acute coronary syndromes. Regular use of Sysplatt 75 significantly lowers the risk of clot-related events in people who have a history of cardiovascular diseases. However, it is important to monitor for signs of bleeding and follow the prescribed regimen carefully.